Biotherapeutic manufacturing has been improved significantly in terms of productivity and controllability of Critical Quality Attributes (CQA), but fully controllable, scalable, and intensified biomanufacturing is still a distance target.
The University of Massachusetts Lowell (UML) and team are developing and validating a mammalian cell culture system with an integrated continuous USP platform for maximum productivity and closed-loop control of CQA. The new intensified biomanufacturing platform will deliver:
Implement an intensified continuous biomanufacturing platform.
Produce an economically-optimized perfusion operation in a production bioreactor.
Demonstrate advanced control of productivity and CQA during specific stages of continuous operation.
Create a prototype perfusion system for future cGMP implementation.
This new platform will improve manufacturing performance, reduce costs, increase product quality, and ensure greater regulatory compliance.
The project aims to implement an intensified continuous biomanufacturing platform, produce an economically optimized perfusion operation in a production bioreactor, demonstrate advanced control of productivity and CQA during specific stages of continuous operation, and create a prototype perfusion system for future cGMP implementation.
These goals will be accomplished through the platform’s design, which will reduce media consumption, increase cell and biologic yields, automate control of biotherapeutic product yield and quality attributes, and decrease the usage of raw materials for downstream processing.
1.Microfluidic cell retention device building
2.Integration of hardware and software system
3.Perfusion system with media recycle
4.Utilize EK filter for separating lactate and product while retaining most media components
5.Demonstration of CHO productivity and CQA control implementation
Lee, J., Song, S., Park, Do., Wynne, E., Rajendran, A., Han, J., Yoon, S., & Yamanaka, H., (2025), Continuous Nonoclonal Antibody Production Using Media Recycle in Perfusion, Biotechnology and Bioengineering
Lee, J., Yoon, S., Participant, Tuscon, AZ, ECI Cell Culture Engineering, April 27, 2025.
Lee, J., Yoon, S., Speakers, Bioprocess International Boston 2025, Boston, MA September 15, 2025.
Lee, J., Yoon, S., Speakers, Boston, MA American Institute of Chemical Engineering (AIChE) Annual Meeting, November 3, 2025
Lee, J., Yoon, S., Speakers, Integrated Continuous Bioprocessing VII, Croatia, October 6, 2025.
Park, D., Bevacqua, A., Lee, J., Wang, Z., Yoon, S., & Han, J., High-throughput microfluidic cell retention device for perfusion culture, 2023 Bioprocess International, Boston, MA, September 21, 2023.
Park, D., Wynne, E., Lee, J., Bertalan, T., Han, J., Yoon, S., Wang, Z., Song, S., Yamanaka, H., & Rajendran, A., Integrated Continuous USP Platform for Maximum Productivity and Closed-loop Controlled CQA, NIIMBL National Meeting, Washington, DC, June 24, 2024.
Wynne, E., Park, D., Yoon, J., Cui, M., & Han, J., High-throughput Electrokinetic Filter for CHO media Regeneration, MicroTAS 2023, Katowice, Poland, November 14, 2023.
Wynne, E., Yoon, J., Park, D., Cui, M., Morris, C., Lee, J., Wang, Z., Yoon, S., & Han, J. (2024). Regeneration of Spent Culture Media for Sustainable and Continuous mAb Production via Ion Concentration Polarization. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28888
Yoon, S., Integrated USP Platform Process, NIIMBL National Meeting 2023, Washington, DC, June 26, 2023.
Login to the NIIMBL member portal to access additional project information, including presentations, progress updates, reports, and more.
Not yet a member? Learn more about which level of NIIMBL membership is right for you and your organization.

University of Massachusetts System
Massachusetts Institute of Technology
Massachusetts Life Sciences Center
Pfizer, Inc.
Whirlcell LLC.
Yokogawa Corporation Of America